American Healthcare REIT Soars 0.27% to Record High on Strong Q1 Earnings

American Healthcare (AHR) experienced a slight decline of 1.33% today, with the share price surging to a record high, marking an intraday gain of 0.27%.

The strategy of buying American Healthcare REIT (AHR) shares after they reached a recent high and holding for one week delivered substantial returns over the past five years. The strategy yielded an overall return of 171.66%, significantly outperforming the benchmark return of 19.63%. The excess return generated by the strategy was 152.04%, indicating that it delivered substantial gains relative to the benchmark. Moreover, the strategy's compound annual growth rate (CAGR) was 112.08%, which is a robust indicator of its compounding effectiveness. The strategy's volatility was 29.71%, which implies that the strategy's returns were not overly reliant on any single factor and had a broad base of contributors.

Historical Performance: Over the past five years, the strategy of buying AHR shares after they reached a high and holding for one week achieved an overall return of 171.66%. This is a significant outperformance of the benchmark return of 19.63%, indicating that the strategy gained substantial returns relative to the market.

Excess Returns: The strategy's excess return, which is the return generated by the strategy beyond the benchmark return, was 152.04%. This is a substantial amount and suggests that the strategy's investment approach yielded significant gains compared to a passive investment strategy.

Compound Annual Growth Rate (CAGR): The strategy's CAGR was 112.08%, which is a robust indicator of its compounding effectiveness. A high CAGR suggests that the strategy's returns were not only positive but also compounded at a significant rate over the five-year period.

Volatility: The strategy's volatility was 29.71%, which implies that the strategy's returns were not overly reliant on any single factor and had a broad base of contributors. This level of volatility suggests that the strategy's returns were subject to various market factors and not overly concentrated in any one area.

In conclusion, the strategy of buying AHR shares after they reached a recent high and holding for one week delivered strong returns over the past five years. The strategy's high returns, excess returns, and robust CAGR indicate that it was an effective investment approach. However, the strategy's volatility suggests that it was subject to market fluctuations, which investors should be aware of when considering this strategy.

American Healthcare REIT reported a robust financial performance for the first quarter of 2025, with revenue reaching $540.6 million. This strong performance likely contributed to the stock reaching an all-time high.

KeyCorp increased their price target for American Healthcare REIT from $34.00 to $40.00 and gave the company an "overweight" rating, indicating positive expectations for the stock's future performance.

Stratos Wealth Partners LTD acquired 5,891 shares of AHR, which might reflect growing investor confidence in the stock.